MedPath

The clinical value of the Cognitive Assessment Interview - NL (CAI-NL) in people with severe mental illness (EPA) requiring long-term intensive care

Conditions
Schizophrenia
severe mental illness
10039628
Registration Number
NL-OMON49915
Lead Sponsor
entis (Groningen)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
203
Inclusion Criteria

Inclusion criteria for all participants:
-older than 18 years of age
-speak Dutch sufficiently to be able to understand the questions

Inclusion criteria specific for patiënts (88 patients will be included):
-a DSM-5 diagnosis of a psychiatric illness under the definition of severe
mental illness
Inclusion criteria specific for informants (88 informants, i.e. persons who
know the patient to such an extent that they have good knowledge of the daily
functioning of the patient (can be family or casemanagers), will be included):
- Are closely infvolved with the patient either as family or as a case manager
and have good knowledge of the daily functioning of the patient
Inclusion criteria specific for treating clinicians (7 treating clinicians will
be included)
- are involved as a treating clinician (psychologist, psychiatrist, nurse
pracitioner, remedial educationalist) with the patient populuation.
- need to have finished a relevant degree fort he position they hold at the
department ART Zuidlaren.

Inclusion criteria specific for psychologist in training as health
psychologists (20 psychologists will be included)
- Are enrolled in the eductational program of the institute for postmaster
education for psychologists and remedial educationalists (PPO).
- Are employed in a mental health institution, but not at the department ART
Zuidlaren.

Exclusion Criteria

Inability to have a coherent conversation

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameters relate to the psychometric qualities of the<br /><br>CAI-NL, ie inter-rater reliability, content validity and internal consistency.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The primary study parameters relate to the clinical value of the CAI-NL, i.e.<br /><br>feasibility, acceptability and usefulness.</p><br>
© Copyright 2025. All Rights Reserved by MedPath